1 Min Read
May 30 (Reuters) - Swedish Orphan Biovitrum (Sobi)
* Says Kineret approved in Canada for the treatment of neonatal-onset multisystem inflammatory disease (nomid) Source text for Eikon: Further company coverage: (Stockholm Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.